Drug recall
MD-Gastroview, (Diatrizoate Meglumine 660mg and Diatizoate Sodium 100mg, Injection USP), 120mL amber glass…
FDA recall event 25619 · Class III · Tyco Healthcare
Key facts
| Event ID | 25619 |
|---|---|
| Recall numbers | D-179-3 |
| Recalling firm | Tyco Healthcare |
| Product type | Drugs |
| Products | MD-Gastroview, (Diatrizoate Meglumine 660mg and Diatizoate Sodium 100mg, Injection USP), 120mL amber glass, screw cap bottles, 367mg/mL Organically Bound Iodine, Rx only, For Gastrointestinal… |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Misbranded; incorrectly labeled Diatrizoate Meglumine, Diatrizoate Sodium Injection rather than Diatrizoate Meglumine, Diatrizoate Sodium Solution |
| Initiation date | Feb 21, 2003 |
| City | Raleigh |
| Country | United States |
| FEI number | 3003495779 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports